Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

The primary purpose of this study is to assess the safety and tolerability of single and multiple intravenous (IV) doses of GIGA-2339 in participants with chronic Hepatitis B Virus (HBV) infection.

Participants needed: 48
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: GigaGen, Inc.Updated: Jun 25, 2026Locations: 18
Eligibility criteria

Hepatitis B envelope antigen (HBeAg) negative chronic HBV infection for ≥ 6 mont... [+5]

Positive for co-infection with hepatitis C virus (HCV), human immunodeficiency v... [+15]

Read more
Status: Recruiting

A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

The purpose of this study is to assess the safety and tolerability of GIGA-564 and identify the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) level(s) of GIGA-564 in participants with metastatic or locally advanced solid tumor malignancies.

Participants needed: 60
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: GigaGen, Inc.Updated: Apr 10, 2025Locations: 1
Eligibility criteria

Willing and able to provide informed consent. [+14]

Investigational therapy and/or anti-cancer therapy with the potential for late o... [+19]

Read more